Interview with Professor Richard Barker, OBE
The event will be live-streamed on the Society’s YouTube channel, Facebook page, and Twitter Account. No registration required.

Prof Richard Barker is the Founding Director of New Medicine Partners, a global firm assisting public and private sector organisations to accelerate the worldwide development and adoption of precision medicine. He is chairman of the South London Health Innovation Network. He also chairs Metadvice, an AI-based digital health company enabling personalised medicine in Europe and the US. He is a board member of Image Analysis, a UK company using MRI to quantify the impact of therapy on disease and (until its recent acquisition by BMS) also of Celgene, a major US-based bio-therapeutics company.

His 30-year business career in healthcare has spanned biopharmaceuticals, diagnostics and medical informatics in the USA and Europe. He founded the Oxford-UCL Centre for the Advancement of Sustainable Medical Innovation (CASMI), a major UK academic initiative aimed at bringing biomedical advances more rapidly and affordably to patients. The senior roles he previously held include: Director General of the Association of the British Pharmaceutical Industry, General Manager of Healthcare Solutions for IBM, Chief Executive of Chiron Diagnostics (one of the largest global diagnostics companies, subsequently sold to Bayer) and head of McKinsey’s European healthcare practice.

His book on the future of healthcare ‘2030 – The Future of Medicine: Avoiding a Medical Meltdown’ and his second book ‘Bioscience – lost in translation?’ are published by Oxford University Press.
Date: 29 April 2021, 18:30 (Thursday, 1st week, Trinity 2021)
Venue: Venue to be announced
Speaker: Prof Richard Barker (University of Oxford, Collaboration for the Advancement of Sustainable Medical Innovation)
Organiser: Oxford University Scientific Society (University of Oxford)
Organiser contact email address: scientific.society@studentclubs.ox.ac.uk
Booking required?: Not required
Cost: free
Audience: Public
Editor: Luna Li